---
title: "Arcutis Biotherapeutics director Howard G. Welgus disposes of 4,730 common shares worth $127,269.30"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293070196.md"
description: "Arcutis Biotherapeutics director Howard G. Welgus sold 4,730 common shares at $26.91 on July 15, 2026, totaling $127,269.30. He also exercised stock options for 4,096 shares priced between $6.52 and $8.63. Following these transactions, his direct holding of common stock stands at 37,109 shares."
datetime: "2026-07-17T20:02:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293070196.md)
  - [en](https://longbridge.com/en/news/293070196.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293070196.md)
---

# Arcutis Biotherapeutics director Howard G. Welgus disposes of 4,730 common shares worth $127,269.30

-   Arcutis Biotherapeutics director Howard G. Welgus sold 4,730 shares at USD 26.91 on July 15, 2026. \* He exercised stock options for 4,096 shares at USD 6.52 to USD 8.63 on the same day. \* Directly held common stock ended at 37,109 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-048641), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ARQT.US](https://longbridge.com/en/quote/ARQT.US.md)

## Related News & Research

- [Arcutis Biotherapeutics director Howard G. Welgus sells 4,730 common shares for $123,835.71](https://longbridge.com/en/news/296400256.md)
- [Arcutis Biotherapeutics director Howard G. Welgus disposes of 4,731 common shares for $115,957.48](https://longbridge.com/en/news/290121062.md)
- [3 Best Vanguard ETFs to Watch as AI Spending Surges](https://longbridge.com/en/news/295829824.md)
- [Amazon Thinks AI Is About to Change the Way We Shop. Goodbye, Search Bar.](https://longbridge.com/en/news/296251288.md)
- [Did Profitability, Higher 2026 Guidance, and New Commercial Leadership Just Recast Arcutis Biotherapeutics' (ARQT) Investment Narrative?](https://longbridge.com/en/news/295147038.md)